Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KLK Dosing Frequency in Acute Cerebral Ischemic Stroke (MAISKFE)
ChiCTR-IPD-16008508Phase 4Not yet recruiting
- Sponsor
- General Hospital of the Northern Theater Command
- Start
- Jun 2016
- Modality
- Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of Human urinary kallidinogenase in brain infarction and ischemic stroke (2 arms), sponsored by General Hospital of the Northern Theater Command. Planned start Jun 2016; status: not yet recruiting.
02
Drugs
Human urinary kallidinogenase
03
Conditions
brain infarctionischemic stroke
Beyond the preview
Go deeper on ChiCTR-IPD-16008508.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPD-16008508.